High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery: A Randomized Clinical Trial
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: Noninvasive ventilation delivered as bilevel positive airway pressure (BiPAP) is often used to avoid reintubation and improve outcomes of patients with hypoxemia after cardiothoracic surgery. High-flow nasal oxygen therapy is increasingly used to improve oxygenation because of its ease of implementation, tolerance, and clinical effectiveness. OBJECTIVE: To determine whether high-flow nasal oxygen therapy was not inferior to BiPAP for preventing or resolving acute respiratory failure after cardiothoracic surgery. DESIGN AND SETTING: Multicenter, randomized, noninferiority trial (BiPOP Study) conducted between June 15, 2011, and January 15, 2014, at 6 French intensive care units. PARTICIPANTS: A total of 830 patients who had undergone cardiothoracic surgery, of which coronary artery bypass, valvular repair, and pulmonary thromboendarterectomy were the most common, were included when they developed acute respiratory failure (failure of a spontaneous breathing trial or successful breathing trial but failed extubation) or were deemed at risk for respiratory failure after extubation due to preexisting risk factors. INTERVENTIONS: Patients were randomly assigned to receive high-flow nasal oxygen therapy delivered continuously through a nasal cannula (flow, 50 L/min; fraction of inspired oxygen [FiO2], 50%) (n = 414) or BiPAP delivered with a full-face mask for at least 4 hours per day (pressure support level, 8 cm H2O; positive end-expiratory pressure, 4 cm H2O; FiO2, 50%) (n = 416). MAIN OUTCOMES AND MEASURES: The primary outcome was treatment failure, defined as reintubation, switch to the other study treatment, or premature treatment discontinuation (patient request or adverse effects, including gastric distention). Noninferiority of high-flow nasal oxygen therapy would be demonstrated if the lower boundary of the 95% CI were less than 9%. Secondary outcomes included mortality during intensive care unit stay, changes in respiratory variables, and respiratory complications. RESULTS: High-flow nasal oxygen therapy was not inferior to BiPAP: the treatment failed in 87 of 414 patients with high-flow nasal oxygen therapy (21.0%) and 91 of 416 patients with BiPAP (21.9%) (absolute difference, 0.9%; 95% CI, -4.9% to 6.6%; P = .003). No significant differences were found for intensive care unit mortality (23 patients with BiPAP [5.5%] and 28 with high-flow nasal oxygen therapy [6.8%]; P = .66) (absolute difference, 1.2% [95% CI, -2.3% to 4.8%]. Skin breakdown was significantly more common with BiPAP after 24 hours (10% vs 3%; 95% CI, 7.3%-13.4% vs 1.8%-5.6%; P < .001). CONCLUSIONS AND RELEVANCE: Among cardiothoracic surgery patients with or at risk for respiratory failure, the use of high-flow nasal oxygen therapy compared with intermittent BiPAP did not result in a worse rate of treatment failure. The findings support the use of high-flow nasal oxygen therapy in similar patients. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01458444.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Weaning from mechanical ventilation
Boles, J.-M., Bion, J., Connors, A., Herridge, M., Marsh, B., Melot, C., Pearl, R., Silverman, H., Stanchina, M., Vieillard-Baron, A., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00010206 · Cited by 2,064
Non-invasive ventilation in acute respiratory failure
Nava, S., & Hill, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60496-7 · Cited by 1,011
Noninvasive Positive-Pressure Ventilation for Respiratory Failure after Extubation
Esteban, A., Frutos-Vivar, F., Ferguson, N. D., Arabi, Y., Apezteguía, C., González, M., Epstein, S. K., Hill, N. S., Nava, S., Soares, M.-A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032736 · Cited by 894
The Decision to Extubate in the Intensive Care Unit
Thille, A. W., Richard, J.-C. M., & Brochard, L. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1523ci · Cited by 576
Early Noninvasive Ventilation Averts Extubation Failure in Patients at Risk: A Randomized Trial
Ferrer, M., Valencia, M., Nicolas, J. M., Bernadich, O., Badia, J. R., & Torres, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-718oc · Cited by 573
Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients*
Nava, S., Gregoretti, C., Fanfulla, F., Squadrone, E., Grassi, M., Carlucci, A., Beltrame, F., & Navalesi, P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186416.44752.72 · Cited by 552
Maggiore, S. M., Idone, F. A., Vaschetto, R., Festa, R., Cataldo, A., Antonicelli, F., Montini, L., De Gaetano, A., Navalesi, P., & Antonelli, M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0364oc · Cited by 546
Delclaux, C., L'Her, E., Alberti, C., Mancebo, J., Abroug, F., Conti, G., Guérin, C., Schortgen, F., Lefort, Y., Antonelli, M., et al. (2000) · JAMA · doi:10.1001/jama.284.18.2352 · Cited by 512
Corley, A., Caruana, L. R., Barnett, A. G., Tronstad, O., & Fraser, J. F. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer265 · Cited by 496
Cited by
Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure
Rochwerg, B., Brochard, L., Elliott, M. W., Hess, D., Hill, N. S., Nava, S., Navalesi, P., Antonelli, M., Brozek, J., Conti, G., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02426-2016 · Cited by 1,668
Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure
Mauri, T., Turrini, C., Eronia, N., Grasselli, G., Volta, C. A., Bellani, G., & Pesenti, A. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201605-0916oc · Cited by 641
Hernández, G., Vaquero, C., Colinas, L., Cuena, R., González, P., Canabal, A., Sanchez, S., Rodriguez, M. L., Villasclaras, A., & Fernández, R. (2016) · JAMA · doi:10.1001/jama.2016.14194 · Cited by 607
Hernández, G., Vaquero, C., González, P., Subira, C., Frutos-Vivar, F., Rialp, G., Laborda, C., Colinas, L., Cuena, R., & Fernández, R. (2016) · JAMA · doi:10.1001/jama.2016.2711 · Cited by 551
Nishimura, M. (2016) · Respiratory Care · doi:10.4187/respcare.04577 · Cited by 476
Rochwerg, B., Einav, S., Chaudhuri, D., Mancebo, J., Mauri, T., Helviz, Y., Goligher, E. C., Jaber, S., Ricard, J.-D., Rittayamai, N., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06312-y · Cited by 394
ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure
Oczkowski, S., Ergan, B., Bos, L., Chatwin, M., Ferrer, M., Gregoretti, C., Heunks, L., Frat, J.-P., Longhini, F., Nava, S., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01574-2021 · Cited by 388
Bihorac, A., Ozrazgat-Baslanti, T., Ebadi, A., Motaei, A., Madkour, M., Pardalos, P. M., Lipori, G., Hogan, W. R., Efron, P. A., Moore, F., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002706 · Cited by 377
Azoulay, E., Lemiale, V., Mokart, D., Nseir, S., Argaud, L., Pène, F., Kontar, L., Bruneel, F., Klouche, K., Barbier, F., et al. (2018) · JAMA · doi:10.1001/jama.2018.14282 · Cited by 333
Kepreotes, E., Whitehead, B., Attia, J., Oldmeadow, C., Collison, A., Searles, A., Goddard, B., Hilton, J., Lee, M., & Mattes, J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30061-2 · Cited by 312
Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review
Papazian, L., Corley, A., Hess, D., Fraser, J. F., Frat, J.-P., Guitton, C., Jaber, S., Maggiore, S. M., Nava, S., Rello, J., et al. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4277-8 · Cited by 304
Mauri, T., Alban, L., Turrini, C., Cambiaghi, B., Carlesso, E., Taccone, P., Bottino, N., Lissoni, A., Spadaro, S., Volta, C. A., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4890-1 · Cited by 294
High-flow nasal oxygen therapy in intensive care and anaesthesia
Renda, T., Corrado, A., Iskandar, G., Pelaia, G., Abdalla, K., & Navalesi, P. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2017.11.010 · Cited by 280
Positive pressure ventilation in the cardiac intensive care unit
Alviar, C. L., Miller, P. E., McAreavey, D., Katz, J. N., Lee, B., Moriyama, B., Soble, J., van Diepen, S., Solomon, M. A., & Morrow, D. A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.074 · Cited by 271
Nasal high flow reduces dead space
Möller, W., Feng, S., Domanski, U., Franke, K.-J., Celik, G., Bartenstein, P., Becker, S., Meyer, G., Schmid, O., Eickelberg, O., et al. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00584.2016 · Cited by 266
Ou, X., Hua, Y., Liu, J., Gong, C., & Zhao, W. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.160570 · Cited by 109
“Three trials included 1462 patients (77.3% of total study population) and were conducted in the setting of post-extubation respiratory failure, 21,32,33 which may generate potential bias.”
BackgroundMethodResultInfluentialAllocation concealment in randomised controlled trials: are we getting better?: Table 1
Clark, L., Fairhurst, C., & Torgerson, D. J. (2016) · BMJ · doi:10.1136/bmj.i5663 · Cited by 60
Ha, T. S., Oh, D. K., Lee, H.-J., Chang, Y., Jeong, I. S., Sim, Y. S., Hong, S.-K., Park, S., Suh, G. Y., & Park, S. Y. (2024) · Tuberculosis and Respiratory Diseases · doi:10.4046/trd.2024.0039 · Cited by 3
Metadata
- Authors
- Stéphan, F., Barrucand, B., Petit, P., Rézaiguia-Delclaux, S., Médard, A., Delannoy, B., Cosserant, B., Flicoteaux, G., Imbert, A., Pilorge, C., & Bérard, L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-06-16
- Volume
- 313
- Issue
- 23
- Pages
- 2331
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1790602952
- Cited by
- 535
- References
- 35
- FWCI
- 45.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.